Newsfiscal.ai
VivoSim Labs Extends Human Tissue Platform to Efficacy Testing
· Published
Article summary
VivoSim Labs has expanded its NAMkind™ platform beyond toxicology to include efficacy testing services using 3D human liver and intestinal disease models.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…